Here, we found ABLIM1 exhibited a distinct expression profile (highly expressed in CRCs compared with adjacent normal counterparts) in CRC than in glioblastoma and high ABLIM1 expression predicted a short DFS time, indicating a different role of ABLIM1 in CRC. The gene discussed is ABLIM1; the disease is glioblastoma.